Clinical trials for medicinal mushrooms: Experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi Mushroom)

International Journal of Medicinal Mushrooms

Volumn 7, Issue 1-2, 2005, Pages 111-117

  Zhou, Shufeng ^a   Gao, Yihuai ^b   Chan, Eli ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Ganoderma lucidum; Immune function; Lingzhi; Polysaccharide; Reishi; Tumor

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; DESOGESTREL PLUS ETHINYLESTRADIOL; DIGOXIN; GANODERMA LUCIDUM EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; LOPERAMIDE; NEFAZODONE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIAZIDE DIURETIC AGENT; TRAZODONE; WARFARIN;

ADVANCED CANCER; ANTIVIRAL ACTIVITY; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DELIRIUM; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; GANODERMA LUCIDUM; HEPATITIS B; HUMAN; HYPERTENSION; HYPOGLYCEMIC ACTIVITY; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; KIDNEY CANCER; LIVER CANCER; LIVER PROTECTION; MANIA; MEDICINAL PLANT; MENSTRUATION DISORDER; MUSHROOM; NEURASTHENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEROTONIN SYNDROME; SYMPTOM; TOXICITY; TREATMENT OUTCOME;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 20844461339     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v7.i12.110     Document Type: Review

References (31)

1. Arlt V. M., Stiborova M., and Schmeiser H. H. 2002. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis, 17, 265-277.
2. Bateman J., Chapman R. D., and Simpson D. 1998. Possible toxicity of herbal remedies. Scot Med J, 43, 7-15.
3. Bhattaram V. A., Graefe U., Kohlert C., Veit M., and Derendorf H. 2002. Pharmacokinetics and bio-availability of herbal medicinal products. Phytomedicine, 9(Suppl 3), 1-33.
4. Boulkta J. I. and Nace A. M. 2000. Safety issues with herbal medicine. Pharmacotherapy, 20, 257-269.
5. Cassileth B. R. 2000. Complementary therapies: the American experience. Support Care Cancer, 8, 16-23.
6. Chang R. 1994. Effective dose of Ganoderma in humans. In: Proc 5th Int Mycol Congr (1994). Vancouver, pp. 117-121.
7. Frank R. and Hargreaves R. 2003. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov, 2, 566-580.
8. Fugh-Berman A. 1999. Herbal medicinals: selected clinical considerations, focusing on known or potential drug-herb interactions. Arch Intern Med, 159, 1957-1958.
9. Fugh-Berman A. 2000. Herb-drug interactions. Lancet, 355, 134-138.
10. Fugh-Berman A. and Ernst E. 2001. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol, 52, 587-595.
11. Galluzzi S., Zanetti O., Binetti G., Trabucchi M., and Frisoni G. B. 2000. Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba. J Neurol Neurosurg Psychiatr, 68, 679-680.
12. Gao Y. H., Chan E., and Zhou S. F. 2004c. Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Rev Int, 60, 123-161.
13. Gao Y. H., Chen G. L., Dai X. H., Ye J. X., and Zhou S. F. 2004a. A Phase I/II study of lingzhi mushroom Ganoderma lucidum (W.Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with coronary heart disease. Int J Med Mushr, 6, 327-334.
14. Gao Y. H., Huang M., Jiang W. Q., and Zhou S. F. 2005b. Antitumor effects and mechanisms of Ganoderma lucidum polysaccharides in mice. Immunol Invest, in press.
15. Gao Y. H., Lan J., Dai X. H., Ye J. X., and Zhou S. F. 2004b. A Phase I/II study of Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int J Med Mushr, 6, 33-39.
16. Gao Y H., Tang W. B., Dai X. H., Gao H., Chen G. L., Ye J. X., Chan E., Koh H. L., Li X. T., and Zhou S. F. 2005a. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food, in press.
17. Gao Y. H., Zhou S. F., Chen G. L., Dai X. H., and Ye J. X. 2002a. A Phase I/II study of a Ganoderma lucidum extract (Ganopoly) in patients with advanced cancer. Int J Med Mushr, 4, 207-214.
18. Gao Y. H., Zhou S. F., Chen G. L., Dai X. H., Ye J. X., and Gao H. 2002b. A Phase I/II study of a Ganoderma lucidum extract in patients with chronic hepatitis B. Int J Med Mushr, 4, 321-327.
19. Gao Y. H., Zhou S. F., Jiang W. Q., Huang M., and Dai X. H. 2003. Effect of Ganopoly, a Ganoderma lucidum polysaccharide extract on the immunological function in advanced-stage cancer patients. Immunol Invest, 32, 201-215.
20. Ingram K. D., Dragosavac G. B., Benner K. G., and Flora K. D. 2000. Risks of drug interactions with St. John's Wort. Am J Gastroenterol, 95, 3323-3324.
21. Izzo A. A. and Ernst E. 2001. Interactions between herbal medicines and prescribed drugs-a systematic review. Drugs, 61, 2163-2175.
22. Jacobson J. S., Workman S. B., and Kronenberg F. 2000. Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol, 18, 668-683.
23. Jones B. D. and Runikis A. M. 1987. Interaction of ginseng with phenelzine. J Clin Psychopharmacol, 7, 201-202.
24. Langmead L. and Rampton D. S. 2001. Herbal treatment in gastrointestinal and liver disease-benefits and dangers. Aliment Pharmacol Ther, 15, 1239-1252.
25. Liu X., Yuan J. P., Chung C. K., and Chen X. J. 2002. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett, 182, 155-161.
26. Tang W. B., Gao Y. H., Chen G. L., Gao H., Dai X. H., Ye J. X., Chan E., Huang M., and Zhou S. F. 2005. A randomised, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract (Ganopoly) in neurasthenia. J Med Food, in press.
27. Wang S. Y., Hsu M. L., Hsu H. C., Tzeng C. H., Lee S. S., Shiao M. S., and Ho C. K. 1997. The antitumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer, 70, 699-705.
28. Windrum P., Hull D. R., and Morris T. C. 2000. Herb-drug interactions. Lancet, 355, 1019-1120.
29. Zhang J. S., Tang Q. J., Zimmerman-Kordmann M., Reutter W., and Fan H. 2002. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci, 71, 623-638.
30. Zhou S. F. and Gao Y. H. 2002. The immunomodulating effects of Ganoderma lucidum (Curt.: Fr) P. Karst (Ling Zhi, Reishi mushroom) (Aphyllophoromycetideae). Int J Med Mushr, 4, 1-11.
31. Zhou S. F., Gao Y. H., Wen Q. J., Huang M., Xu A. L., and Paxton J. W. 2003. Interactions of herbs with cytochrome P450. Drug Metab Rev, 35, 35-98.